Source: Optiscan
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Optiscan Imaging (OIL) releases further information on its new partnership deal at the request of the ASX
  • The company announced yesterday it has penned a distributor partnership with Sinsi Technology for the ViewnVivo device
  • The company today advised the agreement has an initial term of two years, with the ability to extend for a further 12 months
  • The contract includes minimum purchase targets for the distributor, and may be terminated by either party in the event of contract terms
  • Optiscan last traded in the grey at 9.8 cents at 1:15 pm AEST

Optiscan Imaging (OIL) has released further information on its new partnership deal at the request of the ASX.

The company announced yesterday it has penned a distributor partnership with Sinsi Technology for the ViewnVivo device. The deal will see the device released to the greater China market, including Hong Kong and Macau.

Sinsi Technology has over 20 years’ experience representing a range of international organisations in China in the biotechnology and life science sectors. The company is said to have an established service network across the country, which further enhances its ability to represent Optiscan and its ViewnVivo device to the market.

ViewnVivo is a miniaturised fluorescence endomicroscope platform that allows real-time in vivo imaging of living tissue.

The company today advised the agreement has an initial term of two years, with the ability to extend for a further 12 months.

The contract includes minimum purchase targets for the distributor. If these targets are met, the revenue is believed to become material.

Either party holds the option to terminate the agreement in the event of any breach of the contract’s terms.

Optiscan last traded in the grey at 9.8 cents at 1:15 pm AEST.  

OIL by the numbers
More From The Market Herald
Mt Monger Resources (ASX:MTM) - Managing Director, Lachlan Reynolds

" Mt Monger Resources (ASX:MTM) intersects broad REE mineralisation at Pt Kidman

Mt Monger Resources (ASX:MTM) has intersected broad rare earth element (REE) mineralisation at the Pt Kidman…

" Invex Therapeutics (ASX:IXC) receives FDA approval for third-phase Presendin clinical trial

Invex Therapeutics (ASX:IXC) has been given the tick of approval in the US for the development…
The Market Herald Video

" Parabellum Resources (ASX:PBL) eyes $3.9m for Khotgor project, Mongolia

Parabellum Resources (ASX:PBL) taps investors for $3.9 million to fund its work program in both Mongolia…
The Market Herald Video

" R3D Resources (ASX:R3D) to recommence Zeehan zinc slag/matte exports

R3D Resources (ASX:R3D) has been granted permits to recommence exports from its Zeehan zinc slag/matte project…